Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial

Detalles Bibliográficos
Autores principales: Molina-Morant, D., Fernández, M. L., Bosch-Nicolau, P., Sulleiro, E., Bangher, M., Salvador, F., Sanchez-Montalva, A., Ribeiro, A. L. P., de Paula, A. M. B., Eloi, S., Correa-Oliveira, R., Villar, J. C., Sosa-Estani, S., Molina, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644612/
https://www.ncbi.nlm.nih.gov/pubmed/37964376
http://dx.doi.org/10.1186/s13063-023-07659-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644612/
https://www.ncbi.nlm.nih.gov/pubmed/37964376
http://dx.doi.org/10.1186/s13063-023-07659-5

Ejemplares similares